AQR Capital Management - ARATANA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$226,000
+76.6%
62,723
+156.8%
0.00%
Q4 2017$128,000
-14.7%
24,4210.0%0.00%
Q3 2017$150,000
-39.3%
24,421
-28.7%
0.00%
Q2 2017$247,000
+36.5%
34,2320.0%0.00%
Q1 2017$181,000
-61.2%
34,232
-47.4%
0.00%
-100.0%
Q4 2016$467,000
+39.4%
65,079
+81.9%
0.00%0.0%
Q3 2016$335,000
-1.2%
35,773
-41.8%
0.00%0.0%
Q1 2016$339,000
-6.9%
61,485
-5.8%
0.00%0.0%
Q4 2015$364,000
+17.8%
65,277
+78.6%
0.00%0.0%
Q3 2015$309,000
+209.0%
36,554
+265.5%
0.00%
Q3 2014$100,00010,0000.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
March Altus Capital Management LP 218,515$2,045,00012.79%
Broadfin Capital, LLC 3,085,979$28,885,0002.59%
First Light Asset Management, LLC 467,743$4,378,0001.88%
AWM Investment Company, Inc. 1,005,000$9,407,0001.72%
MPM ASSET MANAGEMENT LLC 250,000$2,340,0000.77%
Grandeur Peak Global Advisors, LLC 394,450$3,692,0000.72%
TURNER INVESTMENTS LLC 208,660$1,953,0000.65%
WALL STREET ASSOCIATES 197,400$1,848,0000.63%
TFS CAPITAL LLC 192,848$1,805,0000.43%
GENERAL AMERICAN INVESTORS CO INC 412,101$3,857,0000.39%
View complete list of ARATANA THERAPEUTICS INC shareholders